Search details
1.
Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.
Oncologist
; 29(5): e635-e642, 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38431781
2.
Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
BMC Biotechnol
; 24(1): 30, 2024 May 08.
Article
in English
| MEDLINE | ID: mdl-38720310
3.
Pyrotinib-based therapeutic approaches for HER2-positive breast cancer: the time is now.
Breast Cancer Res
; 25(1): 113, 2023 10 03.
Article
in English
| MEDLINE | ID: mdl-37789330
4.
PIK3CA mutations are associated with pathologic complete response rate to neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.
Br J Cancer
; 128(1): 121-129, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36323880
5.
Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.
Oncologist
; 28(7): e534-e541, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37120151
6.
Frequent EGFR exon 20 insertion in the so-called peripheral-type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognised entity?
Histopathology
; 83(2): 178-192, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36864007
7.
Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data.
BMC Cancer
; 23(1): 29, 2023 Jan 07.
Article
in English
| MEDLINE | ID: mdl-36611131
8.
Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
J Nanobiotechnology
; 21(1): 286, 2023 Aug 22.
Article
in English
| MEDLINE | ID: mdl-37608285
9.
B-Type Natriuretic Peptide Can Distinguish Ischemic Stroke Subtypes Better than Other Cardiac Biomarkers.
Med Sci Monit
; 29: e939829, 2023 Jun 19.
Article
in English
| MEDLINE | ID: mdl-37335813
10.
Establishment and validation of a LC-MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
Biomed Chromatogr
; 36(12): e5501, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36082703
11.
Chiral nanomaterials for tumor therapy: autophagy, apoptosis, and photothermal ablation.
J Nanobiotechnology
; 19(1): 220, 2021 Jul 22.
Article
in English
| MEDLINE | ID: mdl-34294083
12.
Integrated endotoxin-adsorption and antibacterial properties of platelet-membrane-coated copper silicate hollow microspheres for wound healing.
J Nanobiotechnology
; 19(1): 383, 2021 Nov 22.
Article
in English
| MEDLINE | ID: mdl-34809612
13.
Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical Trial.
Oncologist
; 25(12): e1909-e1920, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33000490
14.
SPZ1 promotes deregulation of Bim to boost apoptosis resistance in colorectal cancer.
Clin Sci (Lond)
; 134(2): 155-167, 2020 01 31.
Article
in English
| MEDLINE | ID: mdl-31934723
15.
Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5ß1 interaction and Akt signaling pathway.
Cell Commun Signal
; 18(1): 44, 2020 03 12.
Article
in English
| MEDLINE | ID: mdl-32164705
16.
CD5+MYC+ predicts worse prognosis in diffuse large B-cell lymphoma.
Exp Mol Pathol
; 112: 104326, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31706988
17.
Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer.
J Cell Biochem
; 120(1): 507-518, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30161287
18.
hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR-7-5p and activating the MAPK/ERK signaling pathway.
Mol Carcinog
; 58(4): 554-564, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30520151
19.
Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1.
Cell Physiol Biochem
; 48(4): 1628-1637, 2018.
Article
in English
| MEDLINE | ID: mdl-30071508
20.
The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer.
Future Oncol
; 14(3): 241-253, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-29318915